- Home
- PALI vs NEWT Comparison
PALI vs NEWT Comparison
Compare PALI & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PALI | NEWT |
|---|---|---|
| Founded | 1996 | 1998 |
| Country | United States | United States |
| Employees | N/A | 572 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 359.7M | 400.6M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | PALI | NEWT |
|---|---|---|
| Price | $1.93 | $13.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | $11.29 | ★ $15.33 |
| AVG Volume (30 Days) | ★ 2.6M | 151.0K |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 6.00% |
| EPS Growth | ★ 97.06 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $260,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.45 |
| P/E Ratio | ★ N/A | $5.99 |
| Revenue Growth | ★ 1500.39 | N/A |
| 52 Week Low | $0.55 | $9.59 |
| 52 Week High | $2.86 | $14.91 |
Technical Indicators
Market Signals| Indicator | PALI | NEWT |
|---|---|---|
| Relative Strength Index (RSI) | 47.58 | 58.66 |
| Support Level | $1.57 | $13.43 |
| Resistance Level | $1.96 | $14.32 |
| Average True Range (ATR) | 0.11 | 0.35 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 46.84 | 77.85 |
Price Performance
Historical ComparisonAbout PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
About NEWT NewtekOne Inc.
NewtekOne Inc provides business and financial solutions under the Newtek and NewtekOne brands to the independent business owner (SMB) market. Its services are offered online and in some cases delivered by staff via video and voice calls. The company offers lending products, FDIC insured deposit products and services, payments processing, payroll services and insurance brokerage services. Loan products include SBA 7(a), ALP, SBA 504, and traditional C&I and CRE bank loans, while deposit products include consumer high yield savings accounts, high yield certificates of deposit, zero-fee business checking and business money market accounts. The company operates through four reportable segments Banking, Alternative Lending, NSBF and Payments.